"Three Distinct Stroma Types in Human Pancreatic Cancer Identified by Image Analysis of Fibroblast Subpopulations and Collagen"
clincancerres.aacrjournals.o…
PANIPACproject retweeted
Jacks Lab (@LabJacks) researchers led by Dr. Tyler Jacks and collaborators demonstrated that the CD155/TIGIT axis is critical in maintaining immune evasion in #pancreatic adenocarcinoma.
📍 bit.ly/2VAdJnO
PANIPACproject retweeted
Who will respond to immunotherapy?
This recent paper suggests that the tumor microenvironment falls into 4 categories and can predict therapeutic response: bit.ly/3wQDcXR #AcademicTwitter @MDAndersonNews @BostonGeneCorp
PANIPACproject retweeted
Amazing new publication on a human colorectal cancer-on-chip model to study the microenvironmental influence on early metastatic spread
pubmed.ncbi.nlm.nih.gov/3411…
#microfluidics #colorectalcancer #organonchip #bodyonchip
PANIPACproject retweeted
Researchers show the importance of a dynamic synergistic relationship between patient cells with stromal fibroblasts, in a 3D perfused #vascular network, to accurately recapitulate a dynamic tumor microenvironment.
📌 bit.ly/2Tnnx3r
PANIPACproject retweeted
Let's make sure that everyone with #PancreaticCancer gets the tablets they need to build strength for treatment and improve the quality of their life. We're calling on the NHS to set and meet prescription targets. 💊
Sign today. pancreaticcancer.org.uk/tran… #TransformLivesPrescribe
PANIPACproject retweeted
Thanks to the brilliant work of all our collaborators, we will soon be publishing ‘Pancreatic enzyme replacement therapy in patients with pancreatic cancer’ - #PERT is a key component of #pancreaticcancer care but we are not doing enough to provide it to our patients yet!
PANIPACproject retweeted
Researchers 👩🔬👨🔬 evaluate the synergistic combination of #gemcitabine and #Zebularine in #pancreatic cancer cells.
bit.ly/3vJIyU5
"Lumakras, will be the first on the market to target a tumor growth process called KRAS"
barrons.com/articles/amgen-s…
PANIPACproject retweeted
I am extremely happy to have had the opportunity to present DIVERSA at the DEMO day @LaconNetwork #STARTUPCONGRESSGALICIA
DIVERSA. One technology, limitless applications. Let's start the therapeutic revolution.
Follow #DIVERSA here to keep updated 👇🏻
lnkd.in/eve3spk
Pitch de María de la Fuente Freire de DIVERSA para el #DemoDay del #STARTUPCONGRESSGALICIA
PANIPACproject retweeted
Researchers developed patient-derived xenograft models of #pancreas which could be used as a preclinical tool to better understand the biology of #PancreaticCancers and its underlying impact on effectiveness of therapeutic approaches.
📗 @SciReports
go.nature.com/3hD9hgU
PANIPACproject retweeted
Pancreatic Cancer May Succumb to “Dual Cell” Approach
#Pancreaticcancer could be overcome by SLC7A11-silencing treatments that target both cancer cells and cancer-associated fibroblasts. Learn more: ow.ly/QqY550EMJZ2
We are pleased to present the @panipac @metastarg
website! Find all the groups behind #panipac. @CIBERONC @imos_indo @mfuentefreire @sainz_lab @MuraSimona @ArribasLab @StaniPharm, Pia Protti, José Miguel López #PancreaticCancer #metastarg #metastatic metastarg-panipac.ciberonc.e…
PANIPACproject retweeted
⚠️ Just now on line
Manipulating macrophage polarization in cancer patients: from nanoparticles to human chimeric antigen receptor macrophages – at Bologna, Emilia Romagna
PANIPACproject retweeted
Scientists identify the PAR1‐Myc axis as a driver of ductal cell fates in premalignant #pancreas and pancreatic ductal #adenocarcinoma.
bit.ly/33jLv0X
Suppression of pancreatic ductal adenocarcinoma growth and metastasis by fibrillar collagens produced selectively by tumor cells
nature.com/articles/s41467-0… #PancreaticCancer
Did you know that Pancreatic Cancer has the lowest survival rate of all cancers?
Check out the data of different european countries:
pancreaticcancereurope.eu/en…






















